NeoGenomics annual meeting: all directors elected; say-on-pay passes with 51.79% support

NEOGENOMICS INC

Eight directors elected with votes For ranging from 97.2M (Kelly) to 105.7M (Smith).
Advisory say-on-pay passed narrowly: 51.79% For, 45.37% Against, 2.84% Abstain.
2023 Equity Incentive Plan approved by 95.28% of votes cast (100.8M For).
Ratification of independent auditor approved with 99.82% (113.2M For).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGENOMICS INC shareholders approved Approval of NeoGenomics, Inc. 2023 Equity Incentive Plan at the 2023-05-25 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Number of Votes Outstanding % Voted % For 100,799,248 79.02% 95.28% Against 4,930,366 3.86% 4.67% Abstentions 52,732 0.04% 0.05%

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGENOMICS INC shareholders approved Advisory approval of compensation paid to Named Executive Officers at the 2023-05-25 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Number of Votes Outstanding % Voted % For 54,790,033 42.95% 51.79% Against 47,993,647 37.62% 45.37% Abstentions 2,998,666 2.35% 2.84%

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGENOMICS INC shareholders approved Election of eight directors to serve until the next annual meeting at the 2023-05-25 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Lynn A. Tetrault 100,261,190 5,521,156 — 7,610,467 Christopher M. Smith 105,547,399 234,947 — 7,610,467 Bruce K. Crowther 99,204,967 6,577,379 — 7,610,467 Dr. Alison L. Hannah 104,720,275 1,062,071 — 7,610,467 Stephen M. Kanovsky 104,579,362 1,202,984 — 7,610,467 Michael A. Kelly 97,173,743 8,608,603 — 7,610,467 David B. Perez 105,656,424 125,922 — 7,610,467 Rachel A. Stahler 104,833,843 948,503 — 7,610,467

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGENOMICS INC shareholders approved Ratification of appointment of independent registered public accountant at the 2023-05-25 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Number of Votes Outstanding % Voted % For 113,191,746 88.73% 99.82% Against 163,098 0.12% 0.14% Abstentions 37,969 0.02% 0.04%

View on SEC.gov

550 shareholder votes filed in the last 30 days. Browse all shareholder votes →

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-23-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.